BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 31264121)

  • 1. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
    Back K; Kim JS; Kim JH; Choe JH
    Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Factors for Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
    Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
    Ann Surg Oncol; 2016 Sep; 23(9):2866-73. PubMed ID: 27075321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.
    Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W
    Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
    Zhang X; Zhang L; Xue S; Wang P; Chen G
    Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns, Predictive Factors, and Prognostic Impact of Contralateral Lateral Lymph Node Metastasis in N1b Papillary Thyroid Carcinoma.
    Kim SK; Park I; Hur N; Rayzah M; Lee JH; Choe JH; Kim JH; Kim JS
    Ann Surg Oncol; 2017 Jul; 24(7):1943-1950. PubMed ID: 28160142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
    Zhang Q; Wang Z; Meng X; Duh QY; Chen G
    Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
    Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
    Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
    Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.
    Wang Y; Guan Q; Xiang J
    Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
    Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
    J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
    Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
    J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
    Gui CY; Qiu SL; Peng ZH; Wang M
    J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
    Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
    World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    Nie X; Tan Z; Ge M
    BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of central lymph node metastasis in patientswith thyroid papillary microcarcinoma.
    Akın Ş; Yazgan Aksoy D; Akın S; Kılıç M; Yetişir F; Bayraktar M
    Turk J Med Sci; 2017 Dec; 47(6):1723-1727. PubMed ID: 29306230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
    Zhao L; Sun X; Luo Y; Wang F; Lyu Z
    Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.